US Patent 10946086 Group B
Patent 10946086 was granted and assigned to Pfizer Limited on March, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10946086 Group B
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
